Browse Studies — Arctuva

Phase 1

Study of Intratumoral Injections of VLPONC-01 in Head and Neck Cancer

The goal of this clinical trial is to assess the safety and tolerability of a virus replicon particle (VRP) encapsulated saRNA encoding IL-12 when injected int…

Head and Neck Cancers- Squamous CellHead and Neck CancerSolid Tumors+10 more

Estimated

~$10 – $8,750

VLP TherapeuticsNCT06736379

Phase 1

A First-In-Human Phase I, Open Label, Safety and Tolerability Study of Escalating Multiple Doses of Intratumoral MQ710, a Multi-Transgene Expressing Modified Vaccinia Virus Ankara-Based Virotherapy, Alone and in Combination With the Systemic Checkpoint Inhibitor Pembrolizumab in Solid Tumors

Participants of this study will have a diagnosis of a solid tumor cancer that has come back to its original location or spread beyond its original location (ad…

Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer Center

Phase 1

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

This study is exploring the use of Panitumumab in Head and Neck Cancer. Panitumumab is an approved drug named Vectibix and is used as an anti-cancer agent in o…

HNSCCHNSCC,Larynx, Pharynx and Oral CavitySCC - Squamous Cell Carcinoma

Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT06819228

Phase 1

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

This Phase I, single-institution, open-label study will evaluate the safety, tolerability, and diagnostic performance of \[18F\]NOTA-ABY030 PET/CT in patients …

SCC - Squamous Cell CarcinomaRadiotracerHead and Neck Squamous Cell Carcinoma+1 more

Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT07217028

Observational

High-resolution Specimen PET-CT Imaging for the Intraoperative Visualization of Resection Margins: an Exploratory Study

Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are…

CancerSolid Malignant TumorsSCC - Squamous Cell Carcinoma+2 more

Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT06915454